PBIO Stock - Pressure BioSciences, Inc.
Unlock GoAI Insights for PBIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $1.98M | $1.73M | $2.00M | $1.22M | $1.81M |
| Gross Profit | $799,562 | $-284,661 | $1.06M | $637,737 | $612,932 |
| Gross Margin | 40.4% | -16.5% | 52.9% | 52.2% | 33.9% |
| Operating Income | $-9,503,358 | $-4,898,289 | $-4,185,147 | $-4,585,787 | $-5,805,534 |
| Net Income | $-29,314,298 | $-16,076,678 | $-20,153,486 | $-16,005,543 | $-11,660,917 |
| Net Margin | -1482.2% | -929.6% | -1006.5% | -1311.3% | -644.3% |
| EPS | $-1.51 | $-1.61 | $-3.42 | $-5.32 | $-7.98 |
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.
Visit WebsiteEarnings History & Surprises
PBIOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 5, 2026 | — | — | — | — |
Q1 2025 | Feb 7, 2025 | — | $-0.15 | — | — |
Q4 2024 | Nov 14, 2024 | — | — | — | — |
Q3 2024 | Sep 6, 2024 | — | $-0.22 | — | — |
Q2 2024 | Jun 7, 2024 | — | $-0.30 | — | — |
Q1 2024 | Feb 5, 2024 | — | $-0.28 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.29 | — | — |
Q3 2023 | Aug 21, 2023 | — | $-0.57 | — | — |
Q2 2023 | Apr 18, 2023 | — | $-0.26 | — | — |
Q2 2023 | Apr 12, 2023 | — | $-0.37 | — | — |
Q4 2022 | Nov 22, 2022 | — | $-0.44 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.32 | — | — |
Q2 2022 | May 19, 2022 | — | $-0.48 | — | — |
Q2 2022 | Apr 5, 2022 | — | $-0.40 | — | — |
Q4 2021 | Nov 17, 2021 | — | $-0.82 | — | — |
Q3 2021 | Aug 18, 2021 | — | $-0.90 | — | — |
Q2 2021 | May 17, 2021 | — | $-1.35 | — | — |
Q2 2021 | Apr 15, 2021 | — | $-1.10 | — | — |
Q4 2020 | Nov 17, 2020 | $-2.20 | $-1.02 | +53.6% | ✓ BEAT |
Q3 2020 | Aug 14, 2020 | $-2.22 | $-1.70 | +23.4% | ✓ BEAT |
Latest News
Frequently Asked Questions about PBIO
What is PBIO's current stock price?
What is the analyst price target for PBIO?
What sector is Pressure BioSciences, Inc. in?
What is PBIO's market cap?
Does PBIO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PBIO for comparison